Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.89 USD
−87.96 M USD
5.90 M USD
About MESOBLAST LIMITED
Sector
Industry
CEO
Silviu Itescu
Website
Headquarters
Melbourne
Founded
2004
FIGI
BBG000QD6LZ1
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.